webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

6-O-2-Propyn-1-yl-D-galactose

  CAS No.: 881895-59-6   Cat No.: BADC-00703 4.5  

6-O-2-Propyn-1-yl-D-galactose is a nonclaevable glycolinker for the functionalization of cytotoxic drugs and applications in antibody-drug conjugation.

6-O-2-Propyn-1-yl-D-galactose

Structure of 881895-59-6

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C9H14O6
Molecular Weight
218.2
Shipping
Room temperature, or blue ice upon request.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
6-O-2-Propyn-1-yl-D-galactose
IUPAC Name
2,3,4,5-tetrahydroxy-6-prop-2-ynoxyhexanal
Canonical SMILES
O=C[C@@H]([C@H]([C@H]([C@@H](COCC#C)O)O)O)O
InChI
InChI=1S/C9H14O6/c1-2-3-15-5-7(12)9(14)8(13)6(11)4-10/h1,4,6-9,11-14H,3,5H2
InChIKey
ITQZDWPQQZDNAZ-UHFFFAOYSA-N
Shipping
Room temperature, or blue ice upon request.

6-O-2-Propyn-1-yl-D-galactose is a synthetic carbohydrate derivative with several specialized applications in bioscience. Here are some key applications of 6-O-2-Propyn-1-yl-D-galactose:

Glycobiology Research: This compound is often used in glycobiology to study carbohydrate-protein interactions. By incorporating 6-O-2-Propyn-1-yl-D-galactose into glycan structures, researchers can track and characterize glycosylation patterns on proteins. This assists in understanding how glycosylation affects protein function, stability, and cell signaling.

Metabolic Labeling: 6-O-2-Propyn-1-yl-D-galactose can be employed in metabolic labeling experiments to tag and visualize glycoproteins and glycolipids in cells. When introduced into cellular systems, this sugar analog integrates into glycosylation pathways, allowing for subsequent detection and imaging. This method is pivotal for mapping the spatial and temporal dynamics of glycosylated molecules.

Chemical Biology: In chemical biology, 6-O-2-Propyn-1-yl-D-galactose is used for bioorthogonal chemistry applications such as click chemistry. Its alkyne group allows for specific and efficient labeling reactions, facilitating the conjugation of probes or other functional groups. This enables detailed studies of molecular interactions and the creation of complex biomolecular assemblies.

Drug Delivery Systems: This carbohydrate derivative can be utilized in the design of targeted drug delivery systems. By attaching 6-O-2-Propyn-1-yl-D-galactose to therapeutic agents, researchers can exploit specific carbohydrate-recognition mechanisms to direct drugs to particular cells or tissues. This approach aims to enhance the efficacy and reduce the side effects of treatments.

1.Introducing Glycolinkers for the Functionalization of Cytotoxic Drugs and Applications in Antibody-Drug Conjugation Chemistry
Ekholm FS, Pynnönen H, Vilkman A, Pitkänen V, Helin J, Saarinen J, Satomaa T
Antibody-drug conjugates (ADCs) are promising alternatives to naked antibodies for selective drug-delivery applications and treatment of diseases such as cancer. Construction of ADCs relies upon site-selective, efficient and mild conjugation technologies. The choice of a chemical linker is especially important, as it affects the overall properties of the ADC. We envisioned that hydrophilic bifunctional chemical linkers based on carbohydrates would be a useful class of derivatization agents for the construction of linker-drug conjugates and ADCs. Herein we describe the synthesis of carbohydrate-based derivatization agents, glycolinker-drug conjugates featuring the tubulin inhibitor monomethyl auristatin E and an ADC based on an anti-EGFR antibody. In addition, an initial in vitro cytotoxicity evaluation of the individual components and the ADC is provided against EGFR-positive cancer cells.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: MC-Val-Cit-PAB-MMAF | Br-PEG4-NHBoc | Bocaminooxyacetamide-PEG2-Azido | MMAF Hydrochloride | Azide-C2-Azide | MMAF sodium | Polatuzumab vedotin | PTAD-PEG4-amine | 1-(4-((5-(dimethylcarbamoyl)pyridin-2-yl)disulfanyl)butanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid | 5-azidopentanoic acid N-hydroxysuccinimide ester | 6-O-2-Propyn-1-yl-D-galactose
Send Inquiry
Verification code
Inquiry Basket